N-acetylcysteine does not alter neurometabolite levels in non-treatment seeking adolescents who use alcohol heavily: A preliminary randomized clinical trial
Anna E. Kirkland(Park Centre for Mental Health), Lindsay M. Squeglia(Medical University of South Carolina), James J. Prisciandaro(Medical University of South Carolina), Brittney D. Browning(Park Centre for Mental Health), Kevin M. Gray(Medical University of South Carolina), ReJoyce Green(Medical University of South Carolina), Robert Miranda(Brown University), Dieter J. Meyerhoff(San Francisco VA Medical Center), Pamela L. Ferguson(Park Centre for Mental Health), Helen Liu(Medical University of South Carolina), Rachel L. Tomko(Medical University of South Carolina), Anna M. Maralit(University of Missouri), Kathleen T. Brady(Medical University of South Carolina)
Cited by 13
Related Papers
State-of-the-art behavioral and pharmacological treatments for alcohol use disorder
|The American Journal of Drug and Alcohol Abuse|2018|137
Effects of varenicline on subjective craving and relative reinforcing value of cigarettes
|Drug and Alcohol Dependence|2018|64
Naltrexone effects on subjective responses to alcohol in the human laboratory: A systematic review and meta‐analysis
|Addiction Biology|2019|60
Predictors of Substance Use Initiation by Early Adolescence
|American Journal of Psychiatry|2024|60
Efficacy of Combining Varenicline and Naltrexone for Smoking Cessation and Drinking Reduction: A Randomized Clinical Trial
|American Journal of Psychiatry|2021|37